Scynexis raises $30M in follow-on

Anti-infectives development company Scynexis Inc. (NASDAQ:SCYX) raised $30 million on March 6 in a follow-on underwritten by Guggenheim, Needham, H.C. Wainwright, Roth Capital Partners, CIM and Natio...